CHICAGO, July 13 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX) extended its support for the US Health and Human ServicesDepartment's release today of the final rule on "meaningful use" of an Electronic Health Record (EHR).
"Allscripts, representing our many clients, was pleased to be a participant in the Agency's development of the final rule, and believes that clear guidance can only help accelerate the use of information technology, which will ultimately transform the way healthcare is delivered," said Glen Tullman, Chief Executive Officer of Allscripts. "This is a milestone for our industry and one that sends a clear message to physicians. The tipping point is here and the time to act is now. Physicians can make informed buying decisions with a clear view into what exactly will be required of them and the Electronic Health Record vendor they select. As the market leader, Allscripts is confident that our solutions will be certified to meet or exceed the standards set by the final rule, and we look forward to helping our clients achieve meaningful use and, more importantly, meaningful value from the use of their electronic health record."
Signed into law by President Obama on February 17, 2009, the HITECH Act authorizes the Centers for Medicare & Medicaid Services (CMS) to provide a reimbursement incentive for physician and hospital providers who demonstrate the "meaningful use" of an Electronic Health Record. The incentive payments -- ranging from $44,000 to $64,000 per physician over five years -- begin in 2011 and gradually phase down before penalties for non-EHR use are applied in 2015.
The final rule on meaningful use can be found online at: http://www.ofr.gov/OFRUpload/OFRData/2010-17207_PI.pdf
The final rule on standards, implementation specifications, and certification criteria for EHR technology can be found online at: http://www.ofr.gov/OFRUpload/OFRData/2010-17210_PI.pdf
Allscripts Stimulus Roadmap Webcast
Allscripts will host a webcast at 10 a.m. Central Time on Thursday, July 15, 2010 to review the final rule and provide a roadmap for physician practices hoping to qualify for ARRA incentive payments.
To register for the webcast, follow this link: http://www.allscripts.com/muwebcast715.
Later this month, Allscripts will host a series of more in-depth sessions on the Meaningful Use rules. To register for any of those sessions, follow this link: http://www.allscripts.com/muwebcastseries.
Additional Information on ARRA and Meaningful Use
Allscripts has recently deployed a number of resources to help physician practices demonstrate "meaningful use" and take advantage of the ARRA incentives:
Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and more than 10,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, care management, emergency department information systems and homecare automation. Allscripts is the brand name of AllscriptsMisys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.
For more Allscripts news, follow us on Twitter at: http://twitter.com/AllscriptsMisys
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2009 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.
SOURCE Allscripts-Misys Healthcare Solutions, Inc.
Subscribe to our Free Newsletters!